We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

586:HKEXChina Conch Venture Holdings Ltd. Analysis

Data as of 2026-03-16 - not real-time

NT$11.55

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Taipei Star Bank is trading at TWD 11.55, which sits below its 20‑day (≈11.62), 50‑day (≈11.67) and 200‑day (≈11.93) moving averages, signaling a short‑term bearish bias. The MACD histogram is negative and the MACD line trails its signal, while the RSI hovers around 48.5, indicating neutral momentum but no immediate oversold condition. Volume has been slipping, and the 30‑day volatility is high at roughly 29%, though the beta is essentially flat at –0.08, limiting market‑wide exposure. Fundamentally, the stock trades on a forward PE of about 11.2, well under the industry average of 16.4, and its price‑to‑book ratio of 0.60 suggests a deep discount to book value. The dividend yield of 3.46% is attractive, and the company holds a sizable cash pile (≈TWD 11.7 bn) against modest debt, leaving it effectively net‑cash. Operating margins are healthy at ~19%, but revenue growth is slightly negative at –0.7%, and forward earnings are currently zero, creating a modest earnings uncertainty. Overall, the stock appears undervalued with a solid balance sheet, but technical pressure and muted near‑term earnings could cap upside unless price breaks above the key SMA levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages and near support level
  • Bearish MACD and decreasing volume
  • Attractive dividend yield providing income cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential upside if price clears the 20‑day SMA (~11.62)
  • Undervalued valuation metrics versus industry peers
  • Strong cash position and low leverage supporting stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained net‑cash balance and low debt-to-equity
  • Consistent dividend yield with room for continuation
  • Fundamental value tilt (low PE, low PB) offering long‑run upside

Key Metrics & Analysis

Financial Health

Revenue Growth-0.70%
Profit Margin23.31%
P/E Ratio11.2
ROE5.65%
ROA0.36%
P/B Ratio0.6
Industry P/E16.4

Technical Analysis

TrendBearish
RSI48.5
SupportNT$11.10
ResistanceNT$12.10
MA 20NT$11.62
MA 50NT$11.67
MA 200NT$11.93
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

GradeUndervalued
TypeValue
Dividend Yield3.46%

Risk Assessment

Beta-0.08
Volatility29.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.